The following changes may indicate that the product has degraded and should not be used: Cloudiness or haziness in the solution, which may suggest protein aggregation or contamination Visible particles or floaters suspended within the liquid Discolouration any shift towards brown, orange, or notably deeper yellow tones Crystalline deposits along the walls of the vial or cartridge, which may indicate freezing has occurred Leaking, cracked, or damaged packaging or devices, which compromise sterility It is worth noting that some changes in stability may not be visible to the naked eye, yet the product's potency may still have been compromised by improper storage
The amount of muscle lost in most people who take GLP-1 drugs is similar to whats seen in people who lose weight through diet alone, and in both cases it can be minimized with balanced food choices and exercise (more on that below)
doi:10.1002/jrsm.12 24
SAG : Animal studies show oral SAG (30 mg/kg for 8 weeks) significantly restores liver GSH, reduces GSSG (oxidized glutathione), and lowers lipid peroxidation in CCl-induced liver injury
Vertigo from GLP-1 injections can show up as light-headedness, a spinning sensation, or a general feeling of unsteadiness, especially in the first few weeks or after a dose increase of medications like semaglutide (Wegovy) or tirzepatide (Mounjaro)
This is a legitimate maintenance dose if the side effects at higher levels prove unmanageable or if the weight loss trajectory at 4mg meets your targets